Literature DB >> 21550835

Ferritin as an important player in neurodegeneration.

Andrzej Friedman1, Paolo Arosio, Dario Finazzi, Dariusz Koziorowski, Jolanta Galazka-Friedman.   

Abstract

Oxidative stress is considered one of the pathways leading to neuronal death in neurodegenerative disease. Many published studies aimed to assess the possible role of iron in this process but no consensus has been reached. On the other hand little is known about the role played by the main iron storage protein - ferritin. In this review we discuss the data obtained using several methods - Mössbauer spectroscopy, electron microscopy and ELISA - from human brain tissue both in controls and in four neurodegenerative disorders - Parkinson's (PD) and Alzheimer's disease, progressive supranuclear palsy and neuroferritinopathy. Iron may only cause oxidative stress injury when it is available as labile iron for Fenton reaction. This may be related to the decreased ability of ferritin to retain iron within the iron core of ferritin. This happens in PD and in neuroferritinopathy. In PD there is a decrease in the concentration of L ferritin, while in neuroferritinopathy there is a genetically induced mutation in L ferritin causing its loss of function. We discuss the importance of the ratio H/L ferritin and its changes in neurodegeneration.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550835     DOI: 10.1016/j.parkreldis.2011.03.016

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  37 in total

Review 1.  Industrial toxicants and Parkinson's disease.

Authors:  W Michael Caudle; Thomas S Guillot; Carlos R Lazo; Gary W Miller
Journal:  Neurotoxicology       Date:  2012-01-30       Impact factor: 4.294

2.  Nurr1 and PPARγ protect PC12 cells against MPP(+) toxicity: involvement of selective genes, anti-inflammatory, ROS generation, and antimitochondrial impairment.

Authors:  Mohammad Jodeiri Farshbaf; Mahboobeh Forouzanfar; Kamran Ghaedi; Abbas Kiani-Esfahani; Maryam Peymani; Alireza Shoaraye Nejati; Tayebeh Izadi; Khadijeh Karbalaie; Maryam Noorbakhshnia; Soheila Rahgozar; Hossein Baharvand; Mohammad Hossein Nasr-Esfahani
Journal:  Mol Cell Biochem       Date:  2016-07-19       Impact factor: 3.396

Review 3.  Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism.

Authors:  Lindsay Festa; Olimpia Meucci
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

4.  Changing iron content of the mouse brain during development.

Authors:  Gregory P Holmes-Hampton; Mrinmoy Chakrabarti; Allison L Cockrell; Sean P McCormick; Louise C Abbott; Lora S Lindahl; Paul A Lindahl
Journal:  Metallomics       Date:  2012-07-19       Impact factor: 4.526

Review 5.  Iron metabolism in the CNS: implications for neurodegenerative diseases.

Authors:  Tracey A Rouault
Journal:  Nat Rev Neurosci       Date:  2013-07-03       Impact factor: 34.870

6.  Ferritin light chain interacts with PEN-2 and affects γ-secretase activity.

Authors:  Xinxin Li; Yiqian Liu; Qiuyang Zheng; Guorui Yao; Peng Cheng; Guojun Bu; Huaxi Xu; Yun-wu Zhang
Journal:  Neurosci Lett       Date:  2013-05-15       Impact factor: 3.046

7.  Iron Metabolism in the Peripheral Nervous System: The Role of DMT1, Ferritin, and Transferrin Receptor in Schwann Cell Maturation and Myelination.

Authors:  Diara A Santiago González; Veronica T Cheli; Rensheng Wan; Pablo M Paez
Journal:  J Neurosci       Date:  2019-11-01       Impact factor: 6.167

Review 8.  Senescent Microglia: The Key to the Ageing Brain?

Authors:  Eleanor K Greenwood; David R Brown
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 9.  Iron homeostasis in peripheral nervous system, still a black box?

Authors:  Sonia Levi; Carla Taveggia
Journal:  Antioxid Redox Signal       Date:  2014-03-13       Impact factor: 8.401

10.  FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease.

Authors:  Ye Tian; Juan Lu; Xiaoqian Hao; Hang Li; Guiyu Zhang; Xuelei Liu; Xinrong Li; Caiping Zhao; Weihong Kuang; Dongfeng Chen; Meiling Zhu
Journal:  Neurotherapeutics       Date:  2020-09-21       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.